Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

Leave a Comment / By Market Social / January 31, 2026

The plant will help make Lilly’s experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.

Post navigation

Sandisk’s stock gets ‘one of the most delayed upgrades in history’ after blowout earnings

Bitcoin dips below $78,000 as market digests silver sell-off, Trump’s Fed chair pick

Your email address will not be published. Required fields are marked *

Comment *

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Markets

Trading

About Us

Name * Only alphabets are allowed.

Password

Again Password

Referral (Optional)

Support Language

Whatsapp Number *

OTP